Green Dragon Gas Ltd
26 November 2007
26 November 2007
GREEN DRAGON GAS LTD.
('Green Dragon' or 'the Company')
MERRILL LYNCH INITIATES RESEARCH
Green Dragon Gas Ltd. (AIM: GDG), the Chinese coal bed methane ('CBM') business,
today announces that Merrill Lynch has released a CBM sector report and a
research report on the Company titled 'A green giant awakens'. The analyst
initiated research with a Buy recommendation and a price target of US$10.80 per
share. Both reports are available on the Company's website.
Mr. Randeep S. Grewal, Chairman and CEO, comments, ' The CBM sector report and
research report on the Company highlight the significant growth potential for
CBM in China and the Company's leadership position within this niche. We are
pleased to see an institution like Merrill Lynch pick GDG as a leader within the
Chinese CBM industry'.
For further information on the Company and its activities, please refer to the
website at www.greendragongas.com or contact:
Randeep Grewal
Chairman and Chief Executive, Green Dragon Gas Ltd.
+852 3710 0168
Tim Thompson/ Nick Melson/ Susannah Gale
Buchanan Communications
+ 44 (0)20 7466 5000
Dr Azhic Basirov/ David Jones
Smith & Williamson Corporate Finance Limited
+44 (0)20 7131 4000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.